The management of metastatic radioiodine-refractory differentiated thyroid cancer requires an integrated approach including both directed and systemic therapies

SUMMARY: A 58-year-old man with metastatic radioiodine-refractory differentiated thyroid cancer (DTC) presented with left thigh and right flank numbness. He had known progressive and widespread bony metastases, for which he received palliative radiotherapy, and multiple bilateral asymptomatic pulmon...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooray, Shamil D, Topliss, Duncan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Novel Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404474/
https://www.ncbi.nlm.nih.gov/pubmed/28458901
http://dx.doi.org/10.1530/EDM-16-0089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404474/
https://www.ncbi.nlm.nih.gov/pubmed/28458901
http://dx.doi.org/10.1530/EDM-16-0089

Ejemplares similares